- Home
- FGBI vs ACHV Comparison
FGBI vs ACHV Comparison
Compare FGBI & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGBI
- ACHV
- Stock Information
- Founded
- FGBI 1934
- ACHV N/A
- Country
- FGBI United States
- ACHV Canada
- Employees
- FGBI N/A
- ACHV N/A
- Industry
- FGBI Savings Institutions
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- FGBI Finance
- ACHV Health Care
- Exchange
- FGBI Nasdaq
- ACHV Nasdaq
- Market Cap
- FGBI 158.1M
- ACHV 126.9M
- IPO Year
- FGBI N/A
- ACHV N/A
- Fundamental
- Price
- FGBI $8.77
- ACHV $3.17
- Analyst Decision
- FGBI
- ACHV Strong Buy
- Analyst Count
- FGBI 0
- ACHV 5
- Target Price
- FGBI N/A
- ACHV $14.80
- AVG Volume (30 Days)
- FGBI 10.5K
- ACHV 229.0K
- Earning Date
- FGBI 01-30-2025
- ACHV 03-27-2025
- Dividend Yield
- FGBI 4.67%
- ACHV N/A
- EPS Growth
- FGBI 31.17
- ACHV N/A
- EPS
- FGBI 0.81
- ACHV N/A
- Revenue
- FGBI $93,143,000.00
- ACHV N/A
- Revenue This Year
- FGBI N/A
- ACHV N/A
- Revenue Next Year
- FGBI $2.98
- ACHV N/A
- P/E Ratio
- FGBI $10.83
- ACHV N/A
- Revenue Growth
- FGBI 1.72
- ACHV N/A
- 52 Week Low
- FGBI $8.39
- ACHV $2.84
- 52 Week High
- FGBI $15.25
- ACHV $5.59
- Technical
- Relative Strength Index (RSI)
- FGBI 18.69
- ACHV 44.06
- Support Level
- FGBI $9.28
- ACHV $3.18
- Resistance Level
- FGBI $10.21
- ACHV $3.59
- Average True Range (ATR)
- FGBI 0.28
- ACHV 0.21
- MACD
- FGBI -0.08
- ACHV 0.01
- Stochastic Oscillator
- FGBI 14.59
- ACHV 19.48
About FGBI First Guaranty Bancshares Inc.
First Guaranty Bancshares Inc provides personalized commercial banking services to its customers in Louisiana, through several banking facilities. The principal business activity of the company includes attracting deposits and investing it together with funds generated from operations and borrowings insecurities and in lending activities to serve the credit needs of its customer base. The company offers commercial real estate loans, commercial and industrial loans, construction and land development loans, agricultural and farmland loans, and to a lesser extent, consumer and multifamily loans.
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.